The patient with oligodendroglioma was [18F]F-DED negative at the lesion site (right frontal cortex) and indicated regional [18F]F-DED binding that followed physiological MAO-B expression in healthy brain, such as the healthy control (Fig. 5) [17, 18]. This evidence concerns the gene MAOB and oligodendroglioma.